Abstract
Chemotherapy with anticancer drugs is known to be beneficial, but like a double-edged sword, it has its own demerits in the form of adverse effects. Cancer chemotherapy-induced thrombocytopenia is troublesome, and platinum-based regimens, namely carboplatin and cisplatin, are known to cause it very commonly. Gemcitabine, in combination with platinum compounds, is known to cause severe thrombocytopenia. Hence, we report a case of thrombocytopenia induced by gemcitabine when used as a single agent in the treatment of ovarian cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 17-18 |
| Number of pages | 2 |
| Journal | Asian Journal of Pharmaceutical and Clinical Research |
| Volume | 10 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 01-01-2017 |
| Externally published | Yes |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacology
- Pharmaceutical Science
- Pharmacology (medical)
Cite this
}
Gemcitabine-induced drop in platelet counts : A case report. / Balaji, O.; Amita, D.; Sereen, R. T.; Navin, P.
In: Asian Journal of Pharmaceutical and Clinical Research, Vol. 10, No. 5, 01.01.2017, p. 17-18.Research output: Contribution to journal › Article
TY - JOUR
T1 - Gemcitabine-induced drop in platelet counts
T2 - A case report
AU - Balaji, O.
AU - Amita, D.
AU - Sereen, R. T.
AU - Navin, P.
PY - 2017/1/1
Y1 - 2017/1/1
N2 - Chemotherapy with anticancer drugs is known to be beneficial, but like a double-edged sword, it has its own demerits in the form of adverse effects. Cancer chemotherapy-induced thrombocytopenia is troublesome, and platinum-based regimens, namely carboplatin and cisplatin, are known to cause it very commonly. Gemcitabine, in combination with platinum compounds, is known to cause severe thrombocytopenia. Hence, we report a case of thrombocytopenia induced by gemcitabine when used as a single agent in the treatment of ovarian cancer.
AB - Chemotherapy with anticancer drugs is known to be beneficial, but like a double-edged sword, it has its own demerits in the form of adverse effects. Cancer chemotherapy-induced thrombocytopenia is troublesome, and platinum-based regimens, namely carboplatin and cisplatin, are known to cause it very commonly. Gemcitabine, in combination with platinum compounds, is known to cause severe thrombocytopenia. Hence, we report a case of thrombocytopenia induced by gemcitabine when used as a single agent in the treatment of ovarian cancer.
UR - http://www.scopus.com/inward/record.url?scp=85018745710&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85018745710&partnerID=8YFLogxK
U2 - 10.22159/ajpcr.2017.v10i5.17297
DO - 10.22159/ajpcr.2017.v10i5.17297
M3 - Article
VL - 10
SP - 17
EP - 18
JO - Asian Journal of Pharmaceutical and Clinical Research
JF - Asian Journal of Pharmaceutical and Clinical Research
SN - 0974-2441
IS - 5
ER -